GRAIL, Inc. (GRAL)
NASDAQ: GRAL · Real-Time Price · USD
97.82
-3.16 (-3.13%)
At close: Jan 30, 2026, 4:00 PM EST
96.32
-1.50 (-1.53%)
After-hours: Jan 30, 2026, 7:56 PM EST
GRAIL Revenue
GRAIL had revenue of $36.19M in the quarter ending September 30, 2025, with 26.32% growth. This brings the company's revenue in the last twelve months to $141.83M, up 20.53% year-over-year. In the year 2024, GRAIL had annual revenue of $125.60M with 34.90% growth.
Revenue (ttm)
$141.83M
Revenue Growth
+20.53%
P/S Ratio
24.12
Revenue / Employee
$141,827
Employees
1,000
Market Cap
3.81B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 125.60M | 32.49M | 34.90% |
| Dec 31, 2023 | 93.11M | 37.56M | 67.61% |
| Jan 1, 2023 | 55.55M | 40.94M | 280.17% |
| Jan 2, 2022 | 14.61M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Charles River Laboratories International | 4.02B |
| Revvity | 2.81B |
| Qiagen | 2.07B |
| RadNet | 1.97B |
| Sotera Health Company | 1.15B |
| Neogen | 880.32M |
| NeoGenomics | 709.16M |
| Veracyte | 495.14M |
GRAL News
- 2 days ago - GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test - PRNewsWire
- 6 days ago - A Study on Aging Unlocks Holy Grail of Sports Performance - GlobeNewsWire
- 12 days ago - GRAIL Inc. - Illumina's Divested Holy Grail - Seeking Alpha
- 19 days ago - GRAIL, Inc. (GRAL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 2 months ago - GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 2 months ago - Deutsche Bank may have just set a holy-grail goal for the S&P 500 - Market Watch
- 2 months ago - GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference - PRNewsWire